These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 2349611)

  • 1. Daily briefing: mRNA vaccines take on flu.
    Graham F
    Nature; 2021 Oct; ():. PubMed ID: 34650242
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
    Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK
    Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for fluphenazine sulfoxide in human plasma.
    Midha KK; Hawes EM; Hubbard JW; McKay G; Rauw G; Sardessai MS; Aravagiri M; Moore MD
    J Pharmacol Methods; 1988 Mar; 19(1):63-74. PubMed ID: 3367650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
    Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK
    Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
    Midha KK; Hubbard JW; Marder SR; Hawes EM; Van Putten T; McKay G; May PR
    Psychopharmacology (Berl); 1987; 93(3):369-73. PubMed ID: 3124166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassay.
    Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Hubbard JW; Midha KK
    Ther Drug Monit; 1990 May; 12(3):268-76. PubMed ID: 2349611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical perspectives of some neuroleptics through development and application of their assays.
    Midha KK; Marder SR; Jaworski TJ; McKay G; Hubbard JW; Hawes EM; Van Putten T; Wirshing WC; Aravagiri M
    Ther Drug Monit; 1993 Jun; 15(3):179-89. PubMed ID: 8101398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.